ATRC AtriCure Inc

Price (delayed)

$68.76

Market cap

$3.13B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.14

Enterprise value

$3.17B

Sector: Healthcare
Industry: Medical Instruments & Supplies

Highlights

The equity has soared by 67% YoY
The debt has contracted by 3.2% YoY
AtriCure's quick ratio has surged by 147% YoY but it has decreased by 6% QoQ
ATRC's net income is down by 37% YoY and by 5% QoQ
AtriCure's EPS has decreased by 21% YoY

Key stats

What are the main financial stats of ATRC
Market
Shares outstanding
45.57M
Market cap
$3.13B
Enterprise value
$3.17B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
7.51
Price to sales (P/S)
14.02
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.33
Earnings
Revenue
$206.53M
EBIT
-$43.16M
EBITDA
-$33.61M
Free cash flow
-$25.13M
Per share
EPS
-$1.14
Free cash flow per share
-$0.6
Book value per share
$9.16
Revenue per share
$4.9
TBVPS
$8.35
Balance sheet
Total assets
$714.54M
Total liabilities
$302.15M
Debt
$74M
Equity
$412.39M
Working capital
$257.6M
Liquidity
Debt to equity
0.18
Current ratio
6.24
Quick ratio
5.44
Net debt/EBITDA
-0.95
Margins
EBITDA margin
-16.3%
Gross margin
72.3%
Net margin
-23.3%
Operating margin
-21.4%
Efficiency
Return on assets
-7.3%
Return on equity
-13.1%
Return on invested capital
-15.2%
Return on capital employed
-6.5%
Return on sales
-20.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ATRC stock price

How has the AtriCure stock price performed over time
Intraday
1.12%
1 week
4.45%
1 month
10.09%
1 year
72.63%
YTD
23.51%
QTD
4.95%

Financial performance

How have AtriCure's revenue and profit performed over time
Revenue
$206.53M
Gross profit
$149.31M
Operating income
-$44.23M
Net income
-$48.16M
Gross margin
72.3%
Net margin
-23.3%
The net margin has plunged by 53% YoY and by 7% from the previous quarter
The operating margin has declined by 49% year-on-year and by 7% since the previous quarter
ATRC's net income is down by 37% YoY and by 5% QoQ
The operating income has decreased by 34% YoY and by 5% from the previous quarter

Growth

What is AtriCure's growth rate over time

Valuation

What is AtriCure stock price valuation
P/E
N/A
P/B
7.51
P/S
14.02
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.33
AtriCure's EPS has decreased by 21% YoY
The equity has soared by 67% YoY
ATRC's price to book (P/B) is 58% higher than its 5-year quarterly average of 4.7 and 43% higher than its last 4 quarters average of 5.2
ATRC's P/S is 162% above its 5-year quarterly average of 5.3 and 63% above its last 4 quarters average of 8.5
ATRC's revenue is down by 11% year-on-year

Efficiency

How efficient is AtriCure business performance
AtriCure's ROS has plunged by 56% YoY and by 8% from the previous quarter
The company's return on invested capital rose by 11% YoY and by 7% QoQ
The ROE has grown by 8% YoY and by 6% from the previous quarter
AtriCure's return on assets has increased by 6% YoY

Dividends

What is ATRC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ATRC.

Financial health

How did AtriCure financials performed over time
AtriCure's total assets is 136% higher than its total liabilities
AtriCure's quick ratio has surged by 147% YoY but it has decreased by 6% QoQ
The current ratio has surged by 117% year-on-year but it has declined by 6% since the previous quarter
The debt is 82% less than the equity
The equity has soared by 67% YoY
The debt to equity has declined by 42% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.